News & Analysis on Clinical Trial Services & Contract Research And Development
Advarra: Gadi Saarony, CEO
By Jenni Spinner
- Last updated on
Advarra—an institutional review board (IRB), institutional biosafety committee (IBC), research quality and compliance consulting services, and standards-based research technology solutions provider—has appointed Gadi Saarony as CRO.
Saarony said regarding his hire, “The team’s commitment to the advancement of clinical research, and to the well-being of clinical trial participants is truly inspiring. Advarra’s capabilities and track record, combined with the healthcare expertise and experience available to it from Genstar, puts us in a great position to innovate, accelerate cycle-times, and drive safety and compliance in support of drug development.”